Rentschler Biopharma

Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, offering end‑to‑end services that span cell line and process development, formulation, analytics, quality control, regulatory support, and GMP manufacturing through to commercial supply. Leveraging a robust quality management system and an operational‑excellence philosophy, the company delivers technology‑driven solutions that accelerate product development and ensure high‑quality biologics. With approximately 1,400 employees, Rentschler Biopharma is a family‑owned firm headquartered in Laupheim, Germany, and operating a U.S. site in Milford, Massachusetts. Its expertise and global footprint make it a trusted partner for biopharma clients seeking reliable, high‑performance development and manufacturing capabilities.